India bans 14 fixed-dose medicines for likely posing risks to healthThe Indian government has banned 14 types of fixed-dose combination (FDC) medicines due to a lack of therapeutic justification and potentia...
Govt bans 14 fixed dose combination drugs, cites they may involve risk to peopleThe expert committee said that there is "no therapeutic justification for this FDC (fixed dose combination) and the FDC may involve risk to...
On a path to recovery; 7 mid-cap pharma stocks with an upside potential up to 47 %After the covid tailwinds got over, pharma stocks witnessed a phase of under-performance. However as the markets get jittery, select pharma...
Defensive Bets: 4 midcaps from pharma sector with ‘Buy’ & ‘Strong Buy’ ratings have upside potential of up to 31%As NIFTY gets even more volatile, there are some sectors which are traditionally considered defensive and they tend to get attention when m...